HTO

Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study

Retrieved on: 
Thursday, September 22, 2022

Voshell Professor of Sports Medicine, Department of Sports Medicine, University of Virginia, presented results from the pivotal Calypso Study of the MISHA Knee System, an implantable shock absorber (ISA) for the treatment of knee osteoarthritis.

Key Points: 
  • Voshell Professor of Sports Medicine, Department of Sports Medicine, University of Virginia, presented results from the pivotal Calypso Study of the MISHA Knee System, an implantable shock absorber (ISA) for the treatment of knee osteoarthritis.
  • The Calypso Study demonstrated superiority of its primary endpoint and reported clinically significant reduction in pain scores and improvement in function scores for participants receiving the MISHA Knee System.
  • Over 90% of the patients receiving the MISHA Knee System experienced substantial, clinically meaningful pain relief and functional improvement.
  • In Dr. Diduchs data presentation of the Calypso Study, the MISHA Knee System met its primary endpoint and was found to be superior to high tibial osteotomy at two years.

International Food Companies recognized for achievements at the 2022 Good Farm Animal Welfare Awards

Retrieved on: 
Wednesday, June 15, 2022

New York City, New York, June 15, 2022 (GLOBE NEWSWIRE) -- Compassion in World Farming is delighted to announce the winners of its 2022 Good Farm Animal Welfare Awards (GFAWAs).

Key Points: 
  • New York City, New York, June 15, 2022 (GLOBE NEWSWIRE) -- Compassion in World Farming is delighted to announce the winners of its 2022 Good Farm Animal Welfare Awards (GFAWAs).
  • The GFAWAs, launched in 2007, recognize food businesses that make meaningful improvements to the lives of farmed animals and the sustainability of their supply chains.
  • This years awards celebrated winners in Europe, Asia, Scandinavia and South America.
  • When Compassion launched its Food Business program over 12 years ago, its mission was to raise the welfare standards of farmed animals used by leading food companies around the world.

Olympus announces acquisition of FH ORTHO, an international orthopedics company in France

Retrieved on: 
Monday, November 2, 2020

By acquiring FH ORTHO, Olympus builds on its portfolio of innovative and patient-focused solutions that are used in MIS procedures in ligament repair, foot & ankle, and trauma surgery.

Key Points: 
  • By acquiring FH ORTHO, Olympus builds on its portfolio of innovative and patient-focused solutions that are used in MIS procedures in ligament repair, foot & ankle, and trauma surgery.
  • Olympus is already active in orthopedics in Japan, where its joint venture Olympus Terumo Biomaterials Corp. distributes products such as bone substitutes and high tibial osteotomy (HTO) plates and screws.
  • Beyond this, Olympus has also developed the first ultrasound device indicated for arthroscopic surgery, supporting more accurate and safer cutting of bones.
  • The acquisition of FH ORTHO will strengthen Olympus group's sales channels by enabling it to expand the distribution of both Olympus' orthopedic products via FH ORTHO's existing distribution channels, as well as to sell certain FH ORTHO key products in Japan.

Olympus announces acquisition of FH ORTHO, an international orthopedics company in France

Retrieved on: 
Monday, November 2, 2020

By acquiring FH ORTHO, Olympus builds on its portfolio of innovative and patient-focused solutions that are used in MIS procedures in ligament repair, foot & ankle, and trauma surgery.

Key Points: 
  • By acquiring FH ORTHO, Olympus builds on its portfolio of innovative and patient-focused solutions that are used in MIS procedures in ligament repair, foot & ankle, and trauma surgery.
  • Olympus is already active in orthopedics in Japan, where its joint venture Olympus Terumo Biomaterials Corp. distributes products such as bone substitutes and high tibial osteotomy (HTO) plates and screws.
  • Beyond this, Olympus has also developed the first ultrasound device indicated for arthroscopic surgery, supporting more accurate and safer cutting of bones.
  • The acquisition of FH ORTHO will strengthen Olympus group's sales channels by enabling it to expand the distribution of both Olympus' orthopedic products via FH ORTHO's existing distribution channels, as well as to sell certain FH ORTHO key products in Japan.

High Tibial Osteotomy (HTO) Plates Market to Reach $269 Mn, Globally, by 2023 at 3.2% CAGR, Says Allied Market Research

Retrieved on: 
Thursday, November 1, 2018

Allied Market Research published a report, titled, High Tibial Osteotomy (HTO) Plates Market by Material (Metals, and Polymers), and Technique (Open-Wedge Technique, Closed-Wedge Technique, and Other): Global Opportunity Analysis and Industry Forecast, 2017-2023.

Key Points: 
  • Allied Market Research published a report, titled, High Tibial Osteotomy (HTO) Plates Market by Material (Metals, and Polymers), and Technique (Open-Wedge Technique, Closed-Wedge Technique, and Other): Global Opportunity Analysis and Industry Forecast, 2017-2023.
  • The report offers extensive analyses of the drivers & opportunities, value chain, market size & projections, key market segments, top investment pockets, and competitive landscape.
  • According to the report, the global high tibial osteotomy (HTO) plates market generated $223 million in 2017 and is expected to reach $269 million by 2023, registering a CAGR of 3.2% from 2017 to 2023.
  • However, high cost of osteotomy surgeries and side effects associated with the usage of plates hamper the market growth.